http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008126034-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0a0e5c07112e1ddbdea9ecb77b4c0b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_073fe63e6b615620d5d813b6366d0856
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17fbb36aa5436905d3737532fe51c8f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e18ef91e60a14ec1a8bd18553ff4d78e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfeeacabfe5fa0c5f9fc75e4a1c254a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a954abc84c5b62e64e0017219f68de03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c471f53f5e9525cb0671e7169a2a7898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ab999f95c380f57d0ea6d65eff36d13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a8f3ae6f1d670415425b7c2bcb5b4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ea4e91d94bd63e4f8230933f774504
publicationDate 2008-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008126034-A3
titleOfInvention Oxazolidinone antibiotics
abstract The invention relates to compounds of formula (I) wherein U, V, W, X, R1, R2, R3, R4, R5, R6, A, B, D, E, G, m and n are as defined in the description, to pharmaceutically acceptable salts of such compounds for use in the manufacture of a medicament for the prevention or treatment of a bacterial infection. Certain compounds of formula (I) are new and are also part of this invention.
priorityDate 2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007060558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081289-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0250040-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069

Total number of triples: 34.